BusinessGilat Unveils Revolutionary Small-Cell-Over-Satellite Solution for 3G and 4G CoverageBy Nasdaq OMXNov 1, 2016, 11:51 AM UTC
BusinessThe Myriad myPath® Melanoma Test Effectively Diagnosed Patients in the Largest Outcomes-Based Study for a Melanoma DiagnosticBy Nasdaq OMXOct 27, 2016, 11:05 AM UTC
BusinessGilat’s Satellite-based Cellular Backhaul Solution Selected by Sprint to Extend LTE Services to Metro Edge and Rural Areas in the USBy Nasdaq OMXOct 26, 2016, 10:34 AM UTC
BusinessMyriad RBM Announces an Agreement with Sanofi to Measure Predictive Cardiovascular Biomarkers in Patients with DiabetesBy Nasdaq OMXOct 25, 2016, 11:05 AM UTC
BusinessAlphatec Spine to Showcase New Minimally Invasive (MIS) and Complex Spine Products at the Upcoming 31st Annual North American Spine Society (NASS) Meeting in BostonBy Nasdaq OMXOct 18, 2016, 8:15 PM UTC
BusinessMyriad Will Present New Data on Its Variant Classification Program at the ASHG Annual MeetingBy Nasdaq OMXOct 17, 2016, 11:05 AM UTC
BusinessMyriad Announces Four Poster Presentations at the 2016 European Society for Medical Oncology (ESMO) Annual MeetingBy Nasdaq OMXOct 7, 2016, 6:15 AM UTC
BusinessEntia Biosciences, Inc. (OTCQB: ERGO) to Present Results of Chronic Kidney Disease Medical Food Clinical Study at American Society of Nephrology / Kidney Week 2016 Annual MeetingBy Nasdaq OMXOct 6, 2016, 4:52 PM UTC
